Clinical Heterogeneity of Patients With Antinuclear Matrix Protein 2 Antibody-Positive Myositis: A Retrospective Cohort Study in China.
Shanshan LiChao SunLing ZhangJunfeng HanHanbo YangSuhao GaoLinrong HePeiyao ZhangXin LuXiaoming ShuGuochun WangPublished in: The Journal of rheumatology (2022)
Patients with myositis who have anti-NXP2 antibodies may present with different phenotypes that are characterized by unique features and prognoses.